CYT006-AngQb
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CYT006-AngQb, covering 2012-08-21 to 2012-08-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb [Phase 1, Phase 2]